Conduit Pharmaceuticals Inc (CDT) Stock Price, Quote & News

Company Profile

CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company's pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto's thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus; and AZD5904, which has completed Phase I clinical trials for the...

Industry: Biotechnology

Sector: Healthcare

Phone: 646 491 9132

Website: www.cdtequity.com

Address:

4581 Tamiami Trail North, Suite 200, Naples, United States

Bears2354 Jul. 15 at 1:53 PM

$CDT

0 · Reply

BigGreenCandle Jul. 15 at 1:03 PM

$CDT It looks like this ticker splits, dumps and repeats. If it splits again the float will be vapor thin though. Any mention of a split yet?

0 · Reply

ka1954 Jul. 15 at 12:15 PM

$CDT $KITT $CWD why a company which declared bankruptcy SOBR, stock is up 200% from bottom? why

0 · Reply

Bears2354 Jul. 14 at 5:02 PM

$CDT ready set .........

1 · Reply

ka1954 Jul. 14 at 4:58 PM

$CDT even stocks that declare bankruptcy are going up 200%+. SOBR news they shut down their operations stock went from .35 to 1.50.

0 · Reply

Sam201 Jul. 13 at 11:54 PM

$VMAR next is $GDC $CDT n maybe$YHC

1 · Reply

JesusIsComingSoon Jul. 13 at 6:41 PM

$CDT Tomorrow or the day after it will explode.

1 · Reply

Nevilhch Jul. 13 at 4:24 PM

$CDT Bears2354 and Sam201, remind me of the movie Dumb and Dumber.

0 · Reply

Bears2354 Jul. 13 at 4:17 PM

$CDT adding some more !!!!

0 · Reply

Sam201 Jul. 13 at 3:45 PM

$CDT he is here too! 😉

0 · Reply

CDT Highlights Sarborg's Application of Quantum Computing to Solid-Form Development

2026-06-18T13:07:10.000Z - 27 days ago

CDT Equity notes investment into Sarborg, expansion into quantum computing

Jun 18, 2026, 8:30 AM EDT - 27 days ago

CDT Notes Strategic Investment into Sarborg and Expansion into Quantum Computing

Jun 16, 2026, 8:30 AM EDT - 4 weeks ago

CDT Equity Announces Debt Update and New Loan Facility

2026-05-28T20:47:21.000Z - 6 weeks ago

CDT Equity receives Nasdaq notice for delayed quarterly report

May 28, 2026, 4:15 PM EDT - 6 weeks ago

CDT Equity Inc. Announces Receipt of Nasdaq Deficiency Letter

2026-05-27T14:17:57.000Z - 7 weeks ago

CDT Equity granted Canadian patent for AZD5904 in male infertility

AZN

May 27, 2026, 8:00 AM EDT - 7 weeks ago

CDT Announces Canadian Patent for AZD5904 in Male Infertility

May 7, 2026, 8:30 AM EDT - 2 months ago

CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market

2026-05-07T04:50:30.000Z - 2 months ago

CDT Equity announces AZD5904 progresses into patent cooperation treaty phase

AZN

May 6, 2026, 8:30 AM EDT - 2 months ago

CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions

2026-04-27T16:25:54.000Z - 2 months ago

CDT Equity management to meet with Maxim

2026-04-22T10:10:41.000Z - 3 months ago

CDT Equity files to sell 5.35M shares of common stock for holders

2026-04-20T17:25:11.000Z - 3 months ago

CDT Equity management to meet with Maxim

2026-04-16T12:47:10.000Z - 3 months ago

CDT Equity expands multi-pathway value creation strategy across pharma, IP

AZN

Apr 16, 2026, 8:30 AM EDT - 3 months ago

CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery

Apr 7, 2026, 8:30 AM EDT - 3 months ago

CDT Notes Sarborg Publication of PRISM Framework Expanding AI

2026-03-27T13:45:58.000Z - 3 months ago

CDT Equity Inc trading resumes

2026-03-27T13:35:40.000Z - 3 months ago

CDT Equity Inc trading halted, volatility trading pause

2026-03-26T23:50:31.000Z - 3 months ago

CDT Equity Inc trading halted, news pending

2026-03-26T13:17:06.000Z - 3 months ago

CDT Equity expands Tapinarof intellectual property portfolio with patent filings

Mar 26, 2026, 8:30 AM EDT - 3 months ago

CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent Filings

2026-03-25T12:27:39.000Z - 4 months ago

CDT Equity announces 1-for-25 reverse stock split

Mar 25, 2026, 8:00 AM EDT - 4 months ago

CDT Equity Inc. Announces Reverse Stock Split

Mar 23, 2026, 8:30 AM EDT - 4 months ago

CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy

2026-03-18T12:46:14.000Z - 4 months ago

CDT Equity announces stockholders approved all proposals at Special Meeting

Mar 18, 2026, 8:30 AM EDT - 4 months ago

CDT Equity Stockholders Approve All Proposals at Special Meeting, Positioning the Company for Next Phase of Growth

2026-03-12T12:36:57.000Z - 4 months ago

CDT Equity notes Sarborg expansion into rare disease signature intelligence

Mar 12, 2026, 8:30 AM EDT - 4 months ago

CDT Notes Sarborg Expansion into Rare Disease Signature Intelligence

2026-03-05T13:47:10.000Z - 4 months ago

CDT Equity notes Sarborg filing of U.S. provisional patent application

Mar 5, 2026, 8:30 AM EST - 4 months ago

CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature Agent

2026-03-04T13:38:28.000Z - 4 months ago

CDT Equity says advancing multiple initiatives to enhance shareholder value

AZN

Mar 4, 2026, 8:30 AM EST - 4 months ago

CDT Positions for Transformational Growth

2026-02-24T13:39:45.000Z - 5 months ago

CDT Equity notes Sarborg expansion into bacteria, agrochemicals

Feb 24, 2026, 8:30 AM EST - 5 months ago

CDT Equity Notes Sarborg Expansion into Bacteria and Agrochemicals

2026-02-20T13:36:27.000Z - 5 months ago

CDT Equity entered into a transaction to acquire a 20% equity stake in Sarborg

Feb 20, 2026, 8:30 AM EST - 5 months ago

CDT Acquires Strategic Stake in Sarborg to Transform its AI-Driven Asset Strategy

2026-01-30T11:11:57.000Z - 5 months ago

CDT Equity files to sell 22.85M shares of common stock for holders

Jan 2, 2026, 8:30 AM EST - 6 months ago

CDT Engages NJS Foresight Bio-Advisory to Support Solid-Form Out-Licensing Strategy

Oct 17, 2025, 8:30 AM EDT - 9 months ago

CDT Equity Increases Bitcoin Holding

Sep 17, 2025, 8:30 AM EDT - 10 months ago

CDT Executes Cryptocurrency Treasury Reserve Strategy

Aug 26, 2025, 8:30 AM EDT - 11 months ago

CDT Equity Identifies New Biological Target Validating AI-Driven Repurposing Strategy

Aug 5, 2025, 8:30 AM EDT - 1 year ago

Conduit to Change Name to CDT Equity Inc.

Jul 8, 2025, 8:30 AM EDT - 1 year ago

Conduit Engages Consultant to Explore Cryptocurrency Reserve Strategy

Jul 7, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries

Jun 4, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health

May 22, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market

May 21, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance

May 16, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Inc. Announces Reverse Stock Split

May 9, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

May 8, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset

Apr 16, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Announces Leadership Changes

Apr 11, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects

Mar 31, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Receives U.S. Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

Mar 19, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Provides Research and Development Update on Progress for Pipeline Assets AZD1656, AZD5658, and AZD5904

Mar 6, 2025, 9:35 AM EST - 1 year ago

Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing Panel

Feb 20, 2025, 8:00 AM EST - 1 year ago

Conduit Progresses Phase II of its AI Initiative with Sarborg

Feb 13, 2025, 8:00 AM EST - 1 year ago

Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model

Feb 11, 2025, 9:00 AM EST - 1 year ago

Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note

Feb 7, 2025, 8:00 AM EST - 1 year ago

Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development

Jan 28, 2025, 5:30 AM EST - 1 year ago

Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence

Dec 12, 2024, 7:30 AM EST - 1 year ago

Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics

Nov 21, 2024, 7:30 AM EST - 1 year ago

Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders

Nov 19, 2024, 4:30 PM EST - 1 year ago

Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors

Nov 4, 2024, 7:30 AM EST - 1 year ago

Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline

Nov 1, 2024, 4:45 PM EDT - 1 year ago

Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes

Aug 12, 2024, 7:00 AM EDT - 2 years ago

Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders

Aug 8, 2024, 6:30 AM EDT - 2 years ago

Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments

May 22, 2024, 7:00 AM EDT - 2 years ago

AstraZeneca furthers ambition to transform outcomes in early lung cancer and redefine metastatic breast cancer treatment at ASCO 2024

AZN

May 21, 2024, 8:00 AM EDT - 2 years ago

Daiichi Sankyo Highlights Progress in Creating New Standards of Care for Patients Across Multiple Cancers at ASCO

Bears2354 Jul. 15 at 1:53 PM

$CDT

0 · Reply

BigGreenCandle Jul. 15 at 1:03 PM

$CDT It looks like this ticker splits, dumps and repeats. If it splits again the float will be vapor thin though. Any mention of a split yet?

0 · Reply

ka1954 Jul. 15 at 12:15 PM

$CDT $KITT $CWD why a company which declared bankruptcy SOBR, stock is up 200% from bottom? why

0 · Reply

Bears2354 Jul. 14 at 5:02 PM

$CDT ready set .........

1 · Reply

ka1954 Jul. 14 at 4:58 PM

$CDT even stocks that declare bankruptcy are going up 200%+. SOBR news they shut down their operations stock went from .35 to 1.50.

0 · Reply

Sam201 Jul. 13 at 11:54 PM

$VMAR next is $GDC $CDT n maybe$YHC

1 · Reply

JesusIsComingSoon Jul. 13 at 6:41 PM

$CDT Tomorrow or the day after it will explode.

1 · Reply

Nevilhch Jul. 13 at 4:24 PM

$CDT Bears2354 and Sam201, remind me of the movie Dumb and Dumber.

0 · Reply

Bears2354 Jul. 13 at 4:17 PM

$CDT adding some more !!!!

0 · Reply

Sam201 Jul. 13 at 3:45 PM

$CDT he is here too! 😉

0 · Reply

falcon630 Jul. 13 at 3:33 PM

$CDT this guy - go all around smallcaps and he's "20k in" something that's down and keeps dropping.

1 · Reply

Nevilhch Jul. 13 at 3:26 PM

$CDT So? Jajaja, I can't help but laugh. I'll say it again. if you want to make money with CDT, short-sell them, there's no other wa

0 · Reply

gkscx Jul. 13 at 3:19 PM

$CDT I look back at this stock and its truly heartbreaking... im hoping those who are holding are not from the highs of June... and those who are that you will get some relief in PR or anything that can end the nosedive this stock is in.

0 · Reply

Sam201 Jul. 13 at 3:04 PM

$CDT 10k more to 55k!

0 · Reply

SC_Hawkeye Jul. 13 at 2:51 PM

$CDT Loaded up low .36's. Bottom may or may not be in, but once it pivots, this should squeeze beautifully.

0 · Reply

TG1019 Jul. 13 at 2:42 PM

$CDT Is this company actively doing nothing to avoid delisting??

0 · Reply

Begtodiffer Jul. 13 at 12:34 PM

$GP $CDT Appreciate how your looking out for us, but im pretty sure we can take care of ourselves, so maybe, Get Lost!

0 · Reply

gkscx Jul. 13 at 12:19 PM

$GP I truly hope for everyone here this is not a repeat of $CDT same pricing action mirroring same pricing dredded quick pop and dump on premarket. They had everyone holding that stock into the ground.. just look at what they did with the R/S... i have no bone in this fight but i worry about the setup and hope it pays out for those who have hope. Either way and be safe and watch your backs and safe trading

1 · Reply

seanolbrych Jul. 13 at 11:59 AM

$CDT one of these am soon we will wake up to a large gap up

0 · Reply

Bullish_Bearish88 Jul. 13 at 11:54 AM

$CDT hate to say it but told you so but

0 · Reply

TacticalTrader752 Jul. 13 at 10:54 AM

$CDT a week from today or it delists

0 · Reply

TacticalTrader752 Jul. 13 at 10:53 AM

$CDT they're really waiting till the buzzer to release (if)..

0 · Reply

Market Cap	5.41M
Revenue (ttm)	0.00
Net Income (ttm)	-17.80M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	109,702
Avg Vol	422,744
Day's Range	N/A - N/A
Shares Out	2.93M
Stochastic %K	5%
Beta	1.93
Analysts	Strong Buy
Price Target	N/A